Vivani Medical, Inc.
VANI
$1.08
$0.088.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -1.18% | -18.39% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.26% | -9.88% | |||
| Operating Income | -1.26% | 9.88% | |||
| Income Before Tax | -1.58% | 8.59% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -1.58% | 8.59% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1.58% | 8.59% | |||
| EBIT | -1.26% | 9.88% | |||
| EBITDA | -1.13% | 10.05% | |||
| EPS Basic | 14.99% | 9.29% | |||
| Normalized Basic EPS | 15.06% | 9.28% | |||
| EPS Diluted | -72.76% | 9.29% | |||
| Normalized Diluted EPS | 15.06% | 9.28% | |||
| Average Basic Shares Outstanding | 19.51% | 0.79% | |||
| Average Diluted Shares Outstanding | 19.51% | 0.79% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||